Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers

Proteomic signatures associated with clinical measures of more aggressive cancers could yield molecular clues as to disease drivers. Here, utilizing the Clinical Proteomic Tumor Analysis Consortium (CPTAC) mass-spectrometry-based proteomics datasets, we defined differentially expressed proteins and...

Descripción completa

Detalles Bibliográficos
Autores principales: Monsivais, Diana, Vasquez, Yasmin, Chen, Fengju, Zhang, Yiqun, Chandrashekar, Darshan S., Faver, John C., Masand, Ramya P., Scheurer, Michael E., Varambally, Sooryanarayana, Matzuk, Martin M., Creighton, Chad J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981264/
https://www.ncbi.nlm.nih.gov/pubmed/33627787
http://dx.doi.org/10.1038/s41388-021-01681-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981264/
https://www.ncbi.nlm.nih.gov/pubmed/33627787
http://dx.doi.org/10.1038/s41388-021-01681-0

Ejemplares similares